Cyclopentolate Hydrochloride
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB00979 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 20 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | cauda equina syndrome | KG + DL |
| 2 | obsolete neurogenic bladder (disease) | KG + DL |
| 3 | irritable bowel syndrome | KG + DL |
| 4 | acute laryngopharyngitis | KG + DL |
| 5 | pharyngitis | KG + DL |
| 6 | nasal cavity disease | KG + DL |
| 7 | uveitis | KG + DL |
| 8 | iris disease | KG + DL |
| 9 | panuveitis (disease) | KG + DL |
| 10 | ciliary body disease | KG + DL |
| 11 | bronchitis | KG + DL |
| 12 | abnormal pupillary function (disease) | KG + DL |
| 13 | benign neoplasm of iris | KG + DL |
| 14 | iris cancer | KG + DL |
| 15 | dry eye syndrome | KG + DL |
| 16 | ciliary body neoplasm | KG + DL |
| 17 | pars planitis | KG + DL |
| 18 | idiopathic uveal effusion syndrome | KG + DL |
| 19 | idiopathic panuveitis | KG + DL |
| 20 | isolated iridoschisis | KG + DL |
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.